NCT04116034View on ClinicalTrials.gov

Alfapump Direct Sodium Removal (DSR) Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 26, 2019

Primary Completion Date

April 15, 2021

Study Completion Date

April 15, 2021

Conditions
Heart FailureCongestive Heart FailureCardiorenal SyndromeVolume OverloadSodium ExcessSodium Disorder
Interventions
DEVICE

alfapump DSR system

Infusion of sodium free Dextrose 10% into peritoneal cavity to remove sodium and fluid using principles of peritoneal dialysis, sodium and ultrafiltrate will be evacuated to the bladder by the alfapump

Trial Locations (2)

9300

OLV Ziekenhuis, Aalst

Unknown

Tbilisi Heart & Vascular Clinic, Tbilisi

All Listed Sponsors
collaborator

Yale University

OTHER

lead

Sequana Medical N.V.

INDUSTRY

NCT04116034 - Alfapump Direct Sodium Removal (DSR) Feasibility Study | Biotech Hunter | Biotech Hunter